Guided Therapeutics Inc financial data

Symbol
GTHP on OTC
Industry
Electromedical & Electrotherapeutic Apparatus
Location
5835 Peachtree Corners East, Suite B, Peachtree Corners, GA
State of incorporation
Delaware
Fiscal year end
December 31
Former names
SPECTRX INC (to 2/28/2008)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 25.3 % -56.8%
Quick Ratio 12.3 % +1.07%
Debt-to-equity -207 % -72.1%
Return On Equity 66.3 %
Return On Assets -138 % +19.2%
Operating Margin -5.59K % +14.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 56.6M shares +10.3%
Common Stock, Shares, Outstanding 54.1K shares
Entity Public Float 11.5M USD +61.6%
Common Stock, Value, Issued 3.44M USD +0.12%
Weighted Average Number of Shares Outstanding, Diluted 56K shares +9.84%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 38K USD -44.9%
Research and Development Expense 431K USD +259%
Selling and Marketing Expense 276K USD +16%
General and Administrative Expense 1.43M USD -65.2%
Operating Income (Loss) -2.12M USD +53%
Nonoperating Income (Expense) -51K USD -3.85%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -709K USD +54.5%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -2.17M USD +59.2%
Earnings Per Share, Basic -0.04 USD/shares +63.6%
Earnings Per Share, Diluted -0.04 USD/shares +63.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 731K USD -72.9%
Accounts Receivable, after Allowance for Credit Loss, Current 2K USD -71.4%
Inventory, Net 632K USD +10.3%
Other Assets, Current 112K USD +23.1%
Assets, Current 1.02M USD -49.7%
Property, Plant and Equipment, Net 28K USD -22.2%
Operating Lease, Right-of-Use Asset 185K USD -30.5%
Other Assets, Noncurrent 17K USD 0%
Assets 1.25M USD -46.7%
Accounts Payable, Current 2.14M USD +0.71%
Accrued Liabilities, Current 840K USD -13.5%
Liabilities, Current 5.73M USD +16.1%
Operating Lease, Liability, Noncurrent 104K USD -48.5%
Liabilities 5.92M USD +4.5%
Retained Earnings (Accumulated Deficit) -152M USD -1.59%
Stockholders' Equity Attributable to Parent -4.67M USD -40.8%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -2.65M USD +47.8%
Liabilities and Equity 1.25M USD -46.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -100K USD +80%
Net Cash Provided by (Used in) Financing Activities -46K USD -300%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 56.3K shares
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 275K USD -79.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 12K USD -74.5%
Deferred Tax Assets, Valuation Allowance 17.9M USD +5.11%
Deferred Tax Assets, Gross 17.9M USD +5.11%
Operating Lease, Liability 203K USD -29.3%
Depreciation 2K USD 0%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 226K USD -33.3%
Property, Plant and Equipment, Gross 1.61M USD -9.93%
Operating Lease, Liability, Current 99K USD +16.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 50K USD -10.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 118K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 23K USD -55.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 50K USD -56.5%
Deferred Tax Assets, Operating Loss Carryforwards 16.4M USD -0.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 118K USD 0%
Additional Paid in Capital 141M USD +0.73%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 14.8K USD -86.1%
Interest Expense 282K USD -21.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%